Health Care & Life Sciences » Biotechnology | Intron Biotechnology Inc.

Intron Biotechnology Inc.

Intron Biotechnology Inc.
Stock Exchange Korea Exchange
EPS
KRW172
Market Cap
KRW628.61 B
Shares Outstanding
15.04 M
Public Float
10.66 M

Profile

Address
Unit 701-704, Joong-Ang Induspia
Seongnam-si GY 13202
Korea, Republic Of
Employees -
Website http://www.intron.co.kr
Updated 09/14/2018
iNtRON Biotechnology, Inc. engages in the development of super-bacteria treatment, antibiotics alternatives, bio new drug, molecular diagnostics and artificial blood. Its products include anti-bacterial agents, identification kits, research reagents and kits. The company was founded on January 18, 1999 and is headquartered in Seongnam-si, South Korea.

Financials

View All
Created with Highcharts 5.0.14Intron Biotechnology Inc.Net Income. Fiscal year is January-December. All values KRW Millions.35435421211 5581 5586106108 3488 3482013201420152016201702k4k6k8k10k
Created with Highcharts 5.0.14Intron Biotechnology Inc.Sales/Revenue. Fiscal year is January-December. All values KRW Millions.9 2779 2779 9809 98011 83511 83510 22210 22210 96310 9632013201420152016201702.5k5k7.5k10k12.5k

In-Joon Song
Non-Executive Director
Jae-Goo Seol
Senior Managing Director